PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
6327714-4	1984	Modification of apo-E2 with cysteamine, which converts the cysteine at position 158 to a positively charged lysine analogue, activates receptor binding approximately 13-fold.	Cysteamine	28-38	apolipoprotein E	Homo sapiens	16-22	
6327714-7	1984	When the Mr = 22,000 fragment was modified with cysteamine and combined with DMPC, receptor binding was further enhanced, attaining the level of activity of normal apo-E3 X DMPC, a 100-fold increase over apo-E2 X DMPC binding.	Cysteamine	48-58	apolipoprotein E	Homo sapiens	164-170	
6327714-7	1984	When the Mr = 22,000 fragment was modified with cysteamine and combined with DMPC, receptor binding was further enhanced, attaining the level of activity of normal apo-E3 X DMPC, a 100-fold increase over apo-E2 X DMPC binding.	Cysteamine	48-58	apolipoprotein E	Homo sapiens	204-210	
6327714-10	1984	The receptor binding of apo-E2-containing beta-very low density lipoproteins could also be activated by cysteamine treatment, with the same retention of enhanced binding activity occurring after the reversal of the modification.	Cysteamine	104-114	apolipoprotein E	Homo sapiens	24-30